MS4A3 and gestational diabetes: We first aimed to test whether lower DNA methylation at ESM1, TSPAN14, and MS4A3, previously detected in blood from adolescent GDM offspring, was present in this older offspring cohort, and subsequently whether these methylation changes were also detectable in the metabolically important subcutaneous adipose tissue (SAT).